This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

People with a high risk of inherited pancreatic cancer

Authoring team

NICE suggest for people with inherited high risk of pancreatic cancer (1)

  • ask people with pancreatic cancer if any of their first-degree relatives has had it

  • surveillance should be offered for pancreatic cancer to people with:
    • hereditary pancreatitis and a PRSS1 mutation
    • BRCA1, BRCA2, PALB2 or CDKN2A (p16) mutations, and one or more first-degree relatives with pancreatic cancer
    • Peutz–Jeghers syndrome

  • surveillance for pancreatic cancer should be considered for people with:
    • 2 or more first-degree relatives with pancreatic cancer, across 2 or more generations
    • Lynch syndrome (mismatch repair gene [MLH1, MSH2, MSH6 or PMS2] mutations) and any first-degree relatives with pancreatic cancer

  • an MRI/MRCP or EUS should be considered for pancreatic cancer surveillance in people without hereditary pancreatitis.
  • a pancreatic protocol CT scan should be considered for pancreatic cancer surveillance in people with hereditary pancreatitis and a PRSS1 mutation.
  • do not offer EUS to detect pancreatic cancer in people with hereditary pancreatitis

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.